🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if Infliximab is safe and effecti...
Status
Completed
Location
Multiple Locations
Start Date
2003-05
Trial ID
NCT00051623
Treatments Being Tested
This is the trial to see how our product is similar to remicade by comparin...
Status
Completed
Location
Hanyang University Medical Center
Start Date
2010-10
Trial ID
NCT01217086
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as infliximab, can locate tumor cell...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-10
Trial ID
NCT00074074
Treatments Being Tested
Study Design: A Prospective Multicenter Randomized Controlled, Open-label ...
Status
Recruiting
Location
Amsterdam UMC AMC
Start Date
2021-11-25
Trial ID
NCT06059989
Treatments Being Tested
The primary objective is to assess if discontinuation of anti- tumor necros...
Status
Completed
Location
Helse Møre og Romsdal, Ålesund Sjukehus
Start Date
2017-06-09
Trial ID
NCT03011268
Treatments Being Tested
RABIOPRED is an in vitro non-invasive blood test, which aims to identify pa...
Status
Terminated
Location
Institute of Rheumatology
Start Date
2016-12
Trial ID
NCT03016260
The purpose of this study is to examine the association with EBV infection,...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00440817
Treatments Being Tested
This study evaluates the efficacy of the addition of infliximab to conventi...
Status
Withdrawn
Location
Shanghai Children's Hospital
Start Date
2020-10
Trial ID
NCT04535518
Treatments Being Tested
Crohn's disease (CD) is an incurable debilitating disorder affecting an inc...
Status
Withdrawn
Location
Pediatric Gastroenterology and Liver Unit
Start Date
2012-12
Trial ID
NCT01752790
Inflammatory bowel disease (IBD) is a chronic immune-related disease, which...
Status
Unknown
Location
The Sixth Affiliated Hospital, Sun Yat-sen University
Start Date
2020-01-01
Trial ID
NCT05542459
Treatments Being Tested